Trial intelligence / Profile preview

Zileuton CR in poorly controlled asthma

NCT00486343Phase 4Terminated

Sponsor
Critical Therapeutics, Inc.
Start
Jul 2007
Primary completion
May 2008
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of zileuton extended release in asthma, sponsored by Critical Therapeutics, Inc.. Started Jul 2007; status: terminated.

02

Drugs

zileuton extended release
03

Conditions

asthma

Beyond the preview

Go deeper on NCT00486343.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00486343.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call